Literature DB >> 11682409

A delayed cardiopulmonary reaction to an intravenous immunosuppressant thymoglobulin after pancreas transplant.

M K Loushin1, I K Hasinoff, K G Belani.   

Abstract

IMPLICATIONS: Adverse cardiopulmonary reaction to an intravenous immunosuppressant after solid organ transplantation might not be evident immediately in the postoperative period and might result in serious cardiopulmonary compromise.

Mesh：

Substances：

Year:  2001        PMID： 11682409     DOI： 10.1097/00000539-200111000-00044

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


  4 in total

1.  Worsening bradycardia following antithymocyte globulin treatment of severe aplastic anemia.

Authors:  Justin Godown; Allison M Deal; Kathy Riley; Frederique Bailliard; Julie Blatt
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

2.  A Double-Blind, Double-Dummy, Flexible-Design Randomized Multicenter Trial: Early Safety of Single- Versus Divided-Dose Rabbit Anti-Thymocyte Globulin Induction in Renal Transplantation.

Authors:  R B Stevens; L E Wrenshall; C D Miles; A C Farney; T Jie; J P Sandoz; T H Rigley; A Osama Gaber
Journal:  Am J Transplant       Date:  2016-03-07       Impact factor: 8.086

3.  An avoidable cause of thymoglobulin anaphylaxis.

Authors:  S Brabant; A Facon; F Provôt; M Labalette; B Wallaert; C Chenivesse
Journal:  Allergy Asthma Clin Immunol       Date:  2017-02-23       Impact factor: 3.406

4.  Bradycardia associated with antithymocyte globulin treatment of a pediatric patient with sickle cell disease: a case report and literature review.

Authors:  Salwa Elazhary; Hanaa Al Alawyat
Journal:  Hematol Transfus Cell Ther       Date:  2020-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.